Symptom-oriented follow-up of early breast cancer is not inferior to conventional control. Results of a prospective multicentre study

Onkologie

Volumn 30, Issue 8-9, 2007, Pages 443-449

  Bornhak, Sven ^a   Heidemann, Else ^a   Herschlein, Hans Joachim ^a   Simon, Wolfgang ^a   Merkle, Elisabeth ^a   Widmaier, Günter ^a   Ernst, Rainer ^a   Greulich, Michael ^a   Bittner, Reinhard ^a   Kieninger, Günther ^a   Merkle, Peter ^a   Strosche, Helmut ^a   Karg, Cornelius ^a   Wellhaeußer, Ulrich ^a   Aulitzky, Walter ^a   Schmidt, Bernhardt ^a   Metzger, Helmut ^a   Hahn, Meike ^a   Stauch, Anette ^b   Meisner, Christoph ^b   Selbmann, Hans Konrad ^b   Regelmann, Christine ^a   Brinkmann, Friedhelm ^a   more..

^a Onkologischer Schwerpunkt Stuttgart   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Breast cancer; Follow up; Survival; Tumour markers

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; IMAGING; LABORATORY TEST; LIVER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTICENTER STUDY; OVERALL SURVIVAL; PATIENT MONITORING; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; ULTRASOUND; BREAST TUMOR; COHORT ANALYSIS; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 35348910138     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000105257     Document Type: Article

References (33)

1. Hellriegel KP, Schulz KD: Nachsorge bei Mammakarzinom-Patientinnen. Empfehlungen einer Konsensus-Tagung. Berlin, 23.-24. Februar 1995. Onkologe 1995;1:405-412.
2. Ohmenhaeuser A, Heidemann E für den Onkologischen Schwerpunkt Stuttgart e.V.: Mammakarzinom - symptomorientierte Nachsorge. Z Allg Med 1996;72:1369-1370.
3. Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG, Sommerfield MR: American Society of Clincal Oncology 1998 update of recommended cancer surveillance guidelines. J Clin Oncol 1998;17:1080-1082.
4. Sauer H: Neuorientierung in der Nachsorge des Mammakarzinoms aus der Sicht der bayerischen Tumorzentren. Bayerisches Aerzteblatt 1995;8:1-16.
5. Lamerz R, Stieber P: Tumour markers. Dtsch med Wschr 2004;129:2722-2728.
6. Pandya KJ, McFadden ET, Kalish LA, Tormey DC, Taylor IV SG and Falkson G: A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group Adjuvant Chemotherapy trials for breast cancer. Cancer 1985;55:202-205.
7. Wandt H, Bruntsch U, Gallmeier WM: Nachsorge beim Mammakarzinom. Dtsch med Wschr 1989;114:1130-1136.
8. Tomin R, Donegan WL: Screening for recurrent breast cancer - its effectiveness and prognostic value. J Clin Oncol 1987;5:62-67.
9. Feig SA: The role of new imaging modalities in staging and follow-up of breast cancer. Sem Oncol 1986;13:402-414.
10. Umbach GE, Holzki C, Perschmann U, Schnörch HG, Bender HG: Erfahrungen in der Nachsorge von Patientinnen mit Mammakarzinom. Geburtsh Frauenheilk 1988;48:292-298.
11. Rosselli Del Turco M, Palli D, Cariddi A, Ciatto A, Pacini P, Distante V: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. J Am Med Ass 1994;271:1593-1597.
12. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. J Am Med Ass 1994;271:1587-1592.
13. Loprinzi CL, Hayes D, Smith T: Doc, shouldn't we be getting some tests? Art of oncology: when the tumour is not the target. J Clin Oncol 2000;11:2345-2348.
14. Sauer H, Hoelzel D: Mammakarzinom - Revision der Nachsorgeempfehlungen. Teil 2: Spezielle Aussagen zu Skelettszintigraphie, Roentgen-Thorax, Lebersonographie und Laboruntersuchungen. Fortschritte der Medizin 1995;14:113.
15. Smith TJ, Heddinger S: Medically Appropriate Follow-Up of Breast and Lung Cancer Patients. 2002, Educational book, Amer Soc Clin Oncol, pp. 652-657.
16. Stierer M, Rosen HR: Influence of early diagnosis on prognosis of recurrent breast cancer. Cancer 1989;64:1128-1131.
17. Kagan AR, Steckel RJ: Routine imaging studies for the post treatment surveillance of breast and colorectal carcinoma. J Clin Oncol 1991;9:837-842.
18. Ravaioli A, Tassinari D, Panzini I, Milandri C, Amadori D: Staging of breast cancer: it is time to break with tradition and initiate the evidence-based-medicine age. J Clin Oncol 2001;19:1234.
19. Jacobs HJ, van Dijck JA, de Kleijn EM, Kiemeney LA, Verbeek AL: Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: a simulation study. Ann Oncol 2001;12:1107-1113.
20. Palli D, Russo A, Saicva C: Intensive vs. clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. JAMA 1999;281:1586.
21. Chen EA, Carlson GA, Coughlin BF, Reed WP Jr, Garb JL, Frank JL: Routine chest roentgenography is unnecessary in the work-up of stage I and II breast cancer. J Clin Onc 2000;18:3503-3506.
22. Hoelzel D, Thieme C: Skeletal szintigraphy in the follow-up of breast cancer. Statistical and epidemiological viewpoints. Dtsch med Wschr 1986;111:1191-1199.
23. Heidemann E: Mammakarzinom: Symptomorientierte Nachsorge. T and E Gynaekologie 1997;10:462-465.
24. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, De Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F: The European Organization for Research and Treatment of Cancer QLQC30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376.
25. Wellek S: A log-rank test for equivalence of two survival functions. Biometrics 1993;94:877-881.
26. Wellek S: Testing Statistical Hypotheses of Equivalence. Boca Raton, FL, Chapman and Hall, 2003.
27. Welt A, Seeber S: Systematische oder symptom-orientierte Nachsorge bei Frauen mit Mammakarzinom. Zentralbl Gynaekol 2005;127:213-216.
28. Thürlimann B, Müller A, Senn HJ: Management of primary breast cancer: an update. Onkologie 2004;27:175-179.
29. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thürlimann B, Senn HJ and panel members: Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005;16:1569-1583.
30. Schwarz R: Assessment of cancer related pain. Onkologie 2006;29:426-428.
31. Budischewski KM, De la Fuente F, Nierhoff CEE, Mose S: The burden of pain of inpatients undergoing radiotherapy - discrepancies in the ratings of physicians and nurses. Onkologie 2006;29:431-435.
32. Peppercorn J, Partridge A, Burstein H J, Winer EP: Standards for follow-up care of patients with breast cancer. Breast 2005;14:500-508.
33. Dershaw DD: Mammographic detection of breast cancer and preoperative needle localization. Sem Surg Oncol 1991;7:247-252.